Clinical Trials Logo

Rhinitis, Allergic, Perennial clinical trials

View clinical trials related to Rhinitis, Allergic, Perennial.

Filter by:

NCT ID: NCT03009136 Recruiting - Clinical trials for Perennial Allergic Rhinitis

Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis

Start date: December 31, 2016
Phase: Phase 3
Study type: Interventional

The aim of this study is to investigate the short and long term efficacy and the safety of SCRT treatment for PAR

NCT ID: NCT02988778 Withdrawn - Clinical trials for Rhinitis, Allergic, Perennial

Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis

RINEX50
Start date: October 8, 2019
Phase: Phase 3
Study type: Interventional

This study is to evaluate non inferiority of Eurofarma budesonide nasal spray x referral Astrazeneca budesonide. Half patients will receive Eurofarma medication and half patients will receive Astrazeneca medication. There is no placebo group.

NCT ID: NCT02972866 Withdrawn - Clinical trials for Rhinitis, Allergic, Perennial

Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis

RINEX32
Start date: June 2016
Phase: Phase 3
Study type: Interventional

This study is to evaluate non inferiority of Eurofarma budesonide nasal spary x referral Astrazeneca budesonide. Half patients will receive Eurofarma medication and half patients will receive Astrazeneca medication. There is no placebo group.

NCT ID: NCT02709538 Completed - Clinical trials for Perennial Allergic Rhinitis

Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)

GSP 301-303
Start date: April 2016
Phase: Phase 3
Study type: Interventional

To evaluate the long term safety and efficacy of GSP 301 NS compared to 2 placebo NS formulations for the treatment of perennial allergic rhinitis (subjects 12 years of age and older)

NCT ID: NCT02686294 Completed - Clinical trials for Rhinitis, Allergic, Perennial

Repeated Dosing Clinical Trial of HL151

Start date: February 16, 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the pharmacokinetic characteristics of bepotastine after multiple oral administration of TALION tab., a IR formulation of bepotastine as reference drug and HL151, a SR formulation of bepotastine as test drug in healthy male adults. Additionally the safety and tolerability of two drugs will be evaluated.

NCT ID: NCT02682745 Completed - Clinical trials for Rhinitis, Allergic, Perennial

Single Dosing Clinical Trial of HL151

Start date: January 15, 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the pharmacokinetic characteristics of bepotastine after single oral administration of TALION tab, a IR formulation of bepotastine as reference drug and HL151, a SR formulation of bepotastine as test drug in healthy male adults. Additionally the safety and tolerability of two drugs will be evaluated.

NCT ID: NCT02653339 Not yet recruiting - Clinical trials for Rhinitis, Allergic, Perennial

Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.

Start date: February 2016
Phase: N/A
Study type: Interventional

This is a controlled clinical trials about traditional Chinese medicine named Qufeng Shengshi Fang,which consisted of cicada slough,bombyx batryticatus,radix angelicae,radix sileris,honeysuckle flower,forsythia,lithospermum and radix glycyrrhizae,and Ebastine on treatment of Allergic Rhinitis.There are 180 Patients with allergic rhinitis recruited from Department of Allergy and Traditional Chinese.To carry on statistical analysis of the result of the self and between-group cross-reference by two questionnaires filled before and after treatment.

NCT ID: NCT02532179 Completed - Asthma Clinical Trials

Subcutaneous Immunotherapy for Mouse in Adults

SCITMO
Start date: October 2015
Phase: Phase 1/Phase 2
Study type: Interventional

This is an open label trial of mouse allergenic extract administered by subcutaneous injection in adults with asthma and mouse sensitivity. The study is designed to evaluate: - the safety of this therapy when given by injection - biomarkers of the immune response and - whether the therapy would be effective in treating allergic asthma.

NCT ID: NCT02498509 Completed - Clinical trials for Rhinitis, Allergic, Perennial

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

Start date: May 2015
Phase: Phase 3
Study type: Interventional

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

NCT ID: NCT02443805 Completed - Clinical trials for Rhinitis, Allergic, Perennial

Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR

Start date: September 29, 2015
Phase: Phase 3
Study type: Interventional

The objective of this study was to assess the efficacy and safety of 12 months of treatment with 300 IR of STG320 sublingual tablets compared with placebo in adults and adolescents with HDM-associated allergic rhinitis.